340B Outlook For 2024: Change. Change. And More Change.

April 19, 2024340B, 340B ESP, Contract Pharmacy, Covered Entities, Drug Manufacturer Restrictions, News Updates, Specialty Drugs, Specialty Drugs, Specialty Pharmacy, Specialty Pharmacy

POST OUTLINE 1) What we’ve learned. What it means for your 340B program. Overview of VytlOne 340B Team experience and successes Dealing with frequent, unexpected changes 2) Potential 340B developments for 2024 National legislation prospects State regulatory changes 3) Legislative & court updates Bill introduced into House Of Representatives Supreme Court overturns 340B restriction cuts … Read More

The Case for Onsite Specialty Pharmacies in 340B Hospitals

April 4, 2024340B, 340B ESP, Bedside Prescription Delivery, Compliance, Covered Entities, Drug Manufacturer Restrictions, Meds To Beds, Prescription Discounts, Requirements, Specialty Drugs, Specialty Drugs, Specialty Pharmacy, Specialty Pharmacy

Why a Specialty Pharmacy? (Overview) As chronic illnesses become increasingly common in the United States, the number of specialty medications for managing these conditions has skyrocketed. According to a report by The American Hospital Association, the number of Americans with chronic medical conditions will grow by a projected 9% between 2020 and 2030, an increase … Read More

Best Practices For A 340B Hospital Looking To Build An Onsite Specialty Pharmacy

March 28, 2024340B, Outpatient Tracking, Retail / Outpatient Pharmacy, Specialty Drugs, Specialty Pharmacy

VytlOne recently gathered three of its corporate executives for an in-depth discussion of how an eligible health system can optimize revenues from its 340B program and its retail pharmacy, to help build and fund an onsite specialty pharmacy. Below is a lightly-edited transcript of that discussion. NOTE: If you’d prefer to watch the complete video … Read More

For Pharmacist Mariana Elia, It’s All About The Relationship

March 20, 2024Meds To Beds, Pharmacy Careers, ProxsysRx Profile, Retail / Outpatient Pharmacy

If you’re a first-time patient of VytlOne’s pharmacy at Tallahassee Memorial Healthcare, and you want to get Mariana Elia talking, really talking, it helps to know key trigger words. Key words and phrases like “Hello,” “How are you?” and “Tell me about yourself.” All highly effective for starting a lively conversation, to be sure. But … Read More

The Best 340B Program Is More Than A 340B Program. Much More.

March 12, 2024340B, Bedside Prescription Delivery, Contract Pharmacy, Drug Manufacturer Restrictions, Meds To Beds, Specialty Drugs, Specialty Pharmacy, TPA / TPAs

Congress established the 340B program in 1992 to help non-profit hospitals fill-in the significant revenue gaps inherent to their business models. What the bill’s supporters did not foresee, and what very few eligible health systems realize — even today — is that 340B can function as the central hub of a multi-point program. One that … Read More

Using 340B To Optimize Patient Care And ROI Throughout Your Health System

March 7, 2024340B, 340B ESP, Bedside Prescription Delivery, Contract Pharmacy, Meds To Beds, Patient Eligibility, Prescription Discounts, Retail / Outpatient Pharmacy, Specialty Drugs, Specialty Pharmacy, TPA / TPAs

Below is a graphic overview of VytlOne’s integrated approach to optimizing a health system’s pharmacy services, savings and revenue. In 340B support alone, we’ve generated over $500 million for the hospitals we serve — revenue those systems have used to positively impact the quality and scope of patient care they offer, in countless ways. Why … Read More

Partnering With Manufacturers To Overcome 340B Specialty Drug Restrictions

March 1, 2024340B, 340B ESP, Bedside Prescription Delivery, Drug Manufacturer Restrictions, Medicare, Meds To Beds, PBM, Specialty Drugs, Specialty Drugs, Specialty Pharmacy

It’s no secret that the 340B Drug Pricing Program has been a lifeline for eligible health systems, enabling them to fill-in the massive revenue gaps inherent to the non-profit-hospital business model (and, in the process, support their mission of providing quality care to our nation’s most vulnerable patients) through access to discounted prescription refills. At … Read More

Your Hospital’s 340B Contract Pharmacy Network Is Not What It Should Be.

February 15, 2024340B, Contract Pharmacy, Covered Entities, Drug Manufacturer Restrictions, Patient Eligibility, PBM, Prescription Discounts, Specialty Drugs, Specialty Drugs, Specialty Pharmacy, Specialty Pharmacy, TPA / TPAs, Uncategorized

Based on our experience, it’s a claim we can make with 100% certainty. VytlOne has supported the 340B programs of more than 100 health systems and health centers since 2019. Altogether, we’ve generated nearly $1 billion in pharmacy-related savings for our clients. While the average 340B hospital’s revenues have decreased significantly since the 2020 advent … Read More